Patents by Inventor BAYLOR RESEARCH INSTITUTE

BAYLOR RESEARCH INSTITUTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140030264
    Abstract: The present invention includes isolated anti-Langerin vaccines, methods for making and using an isolated anti-Langerin antibody or binding fragment thereof and one or more antigenic peptides at the carboxy-terminus of the isolated anti-Langerin antibody, wherein when two or more antigenic peptides are present, the peptides are separated by the one or more linker peptides that comprise at least one glycosylation site. The present invention also includes isolated vectors for the expression of the anti-Langerin antigen delivery vectors and their manufactures and use.
    Type: Application
    Filed: April 15, 2013
    Publication date: January 30, 2014
    Inventor: Baylor Research Institute
  • Publication number: 20130295120
    Abstract: The present invention includes compositions and methods for increasing the effectiveness of antigen presentation using a DCIR-specific antibody or fragment thereof to which an antigen is attached that forms an antibody-antigen complex, wherein the antigen is processed and presented by a dendritic cell that has been contacted with the antibody-antigen complex.
    Type: Application
    Filed: April 29, 2013
    Publication date: November 7, 2013
    Inventor: Baylor Research Institute
  • Publication number: 20130197084
    Abstract: The present invention includes compositions and methods for treating the effects of catabolism in a patient by providing the patient with an amount of an odd-chain fatty acid sufficient to increase the intracellular ratio of AMP to ATP and reduce the activity of AMPK.
    Type: Application
    Filed: March 11, 2013
    Publication date: August 1, 2013
    Applicant: BAYLOR RESEARCH INSTITUTE
    Inventor: BAYLOR RESEARCH INSTITUTE
  • Publication number: 20130164279
    Abstract: The present invention includes methods of detection, diagnosis, prognosis, and treatment of a patient suspected of having a colorectal cancer comprising obtaining one or more samples of the patient, determining a level of expression of miR-148a or the level of methylation of a miR-148a promoter, and predicting a response to a cytotoxic chemotherapy cancer treatment.
    Type: Application
    Filed: December 7, 2012
    Publication date: June 27, 2013
    Applicant: BAYLOR RESEARCH INSTITUTE
    Inventor: BAYLOR RESEARCH INSTITUTE
  • Publication number: 20130123359
    Abstract: According to the present invention, acquired metabolic derangements or fatty acid disorders in humans that are manifested by a deficiency in at least one enzyme involved in fatty acid metabolism are treated with a five carbon or a fifteen carbon fatty acid source. Rapid nutritional supplementation can also be provided to a mammalian cell by providing either a five carbon or fifteen carbon fatty acid source. Dietary formulations suitable for human consumption comprising either a five carbon fatty acid, a fifteen carbon fatty acid or triglycerides thereof is also disclosed.
    Type: Application
    Filed: December 20, 2012
    Publication date: May 16, 2013
    Applicant: Baylor Research Institute
    Inventor: Baylor Research Institute
  • Publication number: 20130122049
    Abstract: The present invention includes compositions and methods for the isolation, purification and preparation of immunogenic antigens for the production of customized cancer vaccines that include dendritic cells that are contacted with an antigen that includes heat-shocked cancer cells.
    Type: Application
    Filed: January 14, 2013
    Publication date: May 16, 2013
    Applicant: BAYLOR RESEARCH INSTITUTE
    Inventor: BAYLOR RESEARCH INSTITUTE